Il Yang to obtain KFDA approval on anti-cancer bulk drug.

Published: 2005-10-31 06:59:00

Updated: 2005-10-31 06:59:00

Il Yang has obtained the KFDA approval for the manufacturing licence of an anti-cancer bulk drug, which was developed from an organism of mushroom called Phellinus linteus for the enhancement of immunity against various GI cancers such as stomach, esophagus, duodenal, sigmoid, rectal and colon cancers and a liver cancer.

The bulk drug has been solely developed by Il Yang research technologi...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.